Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 24, 2005
German health care system in transition. The difficult way to balance cost containment and solidarityJ-Matthias Graf von der SchulenburgThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 25, 2016
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in GermanyAlexander Kuhlmann, J-Matthias Graf von der SchulenburgHealth Economics Review|August 4, 2016
Benefit assessment in Germany: implications for price discountsUlrike Theidel, J-Matthias Graf von der SchulenburgPharmacoeconomics|February 21, 2018
German Value Set for the EQ-5D-5LKristina Ludwig, J-Matthias Graf von der Schulenburg, Wolfgang GreinerThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 6, 2016
Cost analysis of whole genome sequencing in German clinical practiceMarika Plöthner, Martin Frank, J-Matthias Graf von der SchulenburgBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 22, 2016
[Whole-genome sequencing in German clinical practice : Economic impacts of its use in selected areas of application]Marika Plöthner, Martin Frank, J-Matthias Graf von der SchulenburgHealth and Quality of Life Outcomes|February 22, 2017
Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory studyKristina Ludwig, J-Matthias Graf von der Schulenburg, Wolfgang GreinerThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 26, 2022
Dividend policy issues in the European pharmaceutical industry: new empirical evidenceTobias Basse, Christoph Schwarzbach, J-Matthias Graf von der SchulenburgHealth Economics Review|December 14, 2019
Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic reviewAna Babac, Kathrin Damm, J-Matthias Graf von der SchulenburgMedizinische Klinik (Munich, Germany : 1983)|July 21, 2009
[Persistence and frequency of prescriptions of subcutaneous allergen-specific immunotherapy (SCIT) prescribed within the German statutory health insurance]Christa Claes, Thomas Mittendorf, J-Matthias Graf von der SchulenburgPageof 5